Saturday, September 21, 2013 9:45:40 AM
So what if K succeeds... what kind of valuation might we anticipate...
In part 2 I will start small... In part 3 I'll ramp it up a bit...
Let's begin with the lung cancer market in the U.S.... suppose K was approved for tx in this one indication and only in the U.S.... lung cancer tx in U.S. is 10 billion +... about 70% of all lung cancers involve mutation of P53... I posted a source for this information about a week ago... I like using round numbers so let's go with 7 billion as the gross market for K for lung cancer in the U.S....
Since we are playing with numbers let's run two scenarios... the first assuming K captures 10% of market share, the second 15% of market share... including both stand alone and adjuvant possibilities... I don't really know what K's market share might be for this indication... others might be able to help us here... I am just playing with numbers...
10% scenario -
700 million in gross rev
40% profit margin = 280 million
less 50 million in operating expenses = 230 million
P/E ratio of 20 = 4.6 billion market cap
150 million fully diluted = pps of $30.67
15% scenario -
1 billion in gross rev
40% profit margin = 400 million
less 50 million in operating expenses = 350 million
P/E ratio of 20 = 70 billion market cap
150 million fully diluted = pps of $46.76
What is K worth? This math suggests that K targeting only one indication in the U.S. could be worth 30 to 50 dollars per share... of course we know the goal is not to target a single cancer indication just in the U.S... as always... jmo...
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM